The GPT Healthcare IPO has launched on the Indian primary market today. Investors have until February 26, 2024, to participate in the public offering. The mid-sized multi-specialty hospital has set the price range for its shares at ₹177 to ₹186 each.
Strong Listing GPT Healthcare shares made a strong debut on the stock exchanges, listing at a premium of 16.20% over the IPO price on BSE and 15.59% on NSE, listing price 215 on NSE and 216.20 BSE , the day end of trading session it’s closed at 200.70
IPO Details
Details | GPT Healthcare IPO |
---|---|
GMP (Grey Market Premium) | ₹10 (before listing ipo) |
IPO Price Band | ₹177 to ₹186 per equity share |
IPO Date | Opens: 22th Feb, Closes: 26th February 2024 |
IPO Size | ₹525.14 crore (₹40 crore via fresh shares, ₹485.14 crore via OFS) |
Lot Size | 80 shares per lot |
Allotment Date | 27th February 2024 |
Registrar | Link Intime India Private Limited |
Listing Exchanges | BSE and NSE |
Listing Date | 29th February 2024 |
GPT Healthcare IPO Subscription Details
The first-day subscription status of the GPT Healthcare IPO stood at 37%, with the retail portion witnessing a subscription rate of 66%, while Non-Institutional Investors subscribed to 18%. The Qualified Institutional Buyers’ portion was yet to receive bids.
On the second day of subscription, while the retail portion of the GPT Healthcare ipo was fully booked, the overall subscription rate struggled to hit the 100% mark, standing at 85%. As per BSE data, the retail portion was oversubscribed by 1.25 times, with Non-Institutional Investors subscribing to 79% and Qualified Institutional Buyers to 19% of their respective portions.
This IPO commenced its subscription phase on Monday, February 26. The IPO has successfully reached its full subscription mark on the final day, with Non-Institutional Investors leading the charge, closely followed by Qualified Institutional Buyers.
Qualified Institutional Buyers | 17.30x |
Non-Institutional Investor | 11.02x |
Retail Individual Investor | 2.44x |
TOTAL | 8.52x |